CDC-RFA-DD-24-0055: Implementing Evidence-Based Health Promotion Programs for Attention-Deficit Hyperactivity Disorder (ADHD) or Tourette Syndrome (TS)
Closed
This grant is closed. A newer notice from the same program is open now: NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional) (PA-27-100). Status: Due dates in the notice, expires April 5, 2027. It is in our archive of Centers for Disease Control - NCBDDD notices from 2024.
Centers for Disease Control - NCBDDD offered grants of up to $1.1 million (at least $850,000) to any type of organization. It expected to make about 2 awards worth $9.8 million in total. Applications closed on April 15, 2024.
From the official notice on Grants.gov, last changed February 13, 2024. Checked November 7, 2026.
- Award ceiling$1.1 million
- Award floor$850,000
- Total funding$9.8 million
- Expected awards2
- Cost sharingNot required
- Funding typeCooperative Agreement
Key dates
| Posted | February 13, 2024 |
|---|---|
| Deadline | April 15, 2024 |
| Archived by Grants.gov | May 15, 2024 |
Who can apply
This opportunity was open to any type of organization.
All 16 applicant types the notice lists
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Public housing authorities/Indian housing authorities
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- For profit organizations other than small businesses
- Small businesses
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
The award ceiling for this NOFO is $850,000 for Component A and $1,100,000.00 for Component B. CDC will consider any application requesting an award higher than this amount as nonresponsive, and it will receive no further review. Organizations may submit one application for Component A or Component B but cannot apply for both.
Is this a realistic fit?
- Past Birth Defects and Developmental Disabilities - Prevention and Surveillance awards averaged $930,644; this notice allows up to $1.1 million per award.
- Most of the program's money (29% over five years) went to colleges and universities.
- No cost sharing or match is required.
What the grant funds
CDC proposes to allocate funds to implement Notice of Funding Opportunity (NOFO), Implementing Evidence-Based Health Promotion Programs for Attention-Deficit Hyperactivity Disorder (ADHD) or Tourette Syndrome (TS). This NOFO has three main objectives:To improve understanding of, management of, and access to evidence-based services for people with TS or ADHD and their families and communities, equitably reaching those from socioeconomically/geographically/racially/ethnically diverse audiencesTo strengthen the capacity among healthcare professionals to appropriately diagnose and provide evidence-based treatments for persons with the conditionsTo strengthen the capacity among education professionals to implement evidence-based strategies that provide support and facilitate learning and academic success among children with the conditionsCooperative agreement partners will devise, disseminate, evaluate, and continuously improve public health communication and education tools and products to promote evidence-based information about symptoms, diagnosis, and treatment of ADHD or TS for persons with the condition, their families, providers, and educators. Racial, ethnic, geographic, and socioeconomic information will be collected, when possible, to evaluate and continuously improve communication channels in an effort for programs and products to equitably reach the most diverse audiences possible.
Who has won Birth Defects and Developmental Disabilities - Prevention and Surveillance grants before
From fiscal 2021 to 2025, Birth Defects and Developmental Disabilities - Prevention and Surveillance (93.073) awarded $94.9 million across 102 grant awards, an average of $930,644 per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| The Johns Hopkins University | Maryland | 2 | $5.7 million |
| University of North Carolina at Chapel Hill | North Carolina | 4 | $4.9 million |
| University of Texas at Austin | Texas | 2 | $4.2 million |
| Massachusetts Department of Public Health | Massachusetts | 3 | $3.6 million |
| The University of Iowa | Iowa | 3 | $3.5 million |
Applying now
This notice no longer takes applications. Apply under the newer notice, PA-27-100, which is open now.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is CDC-RFA-DD-24-0055 still open?
No. It closed on April 15, 2024. A newer notice is open: PA-27-100, due dates in the notice, expires April 5, 2027.
Who can apply for Implementing Evidence-Based Health Promotion Programs for Attention-Deficit Hyperactivity Disorder (ADHD) or Tourette Syndrome (TS)?
Centers for Disease Control - NCBDDD accepted applications from any type of organization. The notice adds further conditions, so read its eligibility section.
What is the deadline for Implementing Evidence-Based Health Promotion Programs for Attention-Deficit Hyperactivity Disorder (ADHD) or Tourette Syndrome (TS)?
Closed April 15, 2024. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
Awards of up to $1.1 million each. About $9.8 million in total across about 2 awards.
Who has won Birth Defects and Developmental Disabilities - Prevention and Surveillance grants before?
The largest recipients over five fiscal years were The Johns Hopkins University, University of North Carolina at Chapel Hill, University of Texas at Austin. The program made 102 awards worth $94.9 million in that time.
Similar open grants
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)